Clinical Trial

Dazucorilant in Patients With Amyotrophic Lateral Sclerosis

Name: Dazucorilant in Patients With Amyotrophic Lateral Sclerosis — clinical trial record (NCT05407324)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: DAZALS

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The purpose of this 2-part study is to assess the safety and efficacy of CORT113176 (dazucorilant) in patients with Amyotrophic Lateral Sclerosis (ALS).

Protocol Amendment History 1 change

notable Primary completion pushed: 2026-09 -> 2026-10 2026-06-17

Trial Details

NCT Number	NCT05407324
Lead Sponsor	Corcept Therapeutics
Conditions	Amyotrophic Lateral Sclerosis
Enrollment	279 participants
Start Date	2022-11-15
Primary Completion	2026-10 (estimated)
Study Completion	2027-11 (estimated)
Updated on ClinicalTrials.gov	2026-06-16